Press release on receipt of USFDA approval for ADQUEY (difamilast 1%) Ointment.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
13-Feb-2026
Download PDF
Aurobindo Pharma
Press release on receipt of USFDA approval for ADQUEY (difamilast 1%) Ointment.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]